National Nanotechnology Innovation Summit

Posted on July 30, 2010 by Helen Kim

 

A National Nanotechnology Innovation Summit to mark the 10th anniversary of the National Nanotechnology Initiative (NNI) will be held December 8-10, 2010 at the Gaylord National Hotel & Convention Center in National Harbor, MD. The Nano Science and Technology Institute (NTSI) will join with the White House Office of Science & Technology (OSTP), the Nanotechnology Coordination Office (NNCO) and the National Venture Capital Association (NCVA) to organize the event. Launched in 2001, the NNI is a federal program which serves as the coordinating body for 25 federal agencies which conduct nanotechnology research and development. The Summit will be a forum for the nation’s top nanotechnology researchers, investors, policy makers, and developers to join in recognition of the NNI’s efforts in the field over the past ten years. More information and registration details are available at: http://www.nsti.org/events/NNI  

Tags: , , ,

Nanotechnology Conference: Food & Drug Law Institute

Posted on January 15, 2009 by John C. Monica, Jr.

The Food & Drug Law Institute is holding its 2nd Annual Conference on Nanotechnology Law, Regulation and Policy on February 18-19, 2009 at the L’Enfant Plaza Hotel in Washington, DC.  Register here.

Topics include:

  • What progress is FDA making in implementing its Nanotechnology Task Force Report?
  • What can FDA learn from EPA and other oversight agencies the National Nanotechnology Initiative (NNI)?
  • Will the Democratic Congress invest in and/or regulate nanotechnology more than under the Bush Administration?
  • Are workers exposed to asbestos-like dangers from dealing with nano products?
  • How does a responsible company devise a risk management plan for nanotech
  • development — one that takes into account OSHA and NIOSH policy?
  • What is reasonable and required federal funding for U.S nanotechnology R&D, including monies for safety and social policy research?
  • Are China and Japan ahead of the U.S. in nanotech development?
  • For nanotech products and processes, should particle size make a regulatory difference?
Tags: , , , , , ,